NCT03170206 Clinical Trials
Find a Pfizer study that’s right for you by searching for conditions, keywords or a National Clinical Trials (NCT) number. You can also see nearby clinical trials by entering your ZIP code or city.
1 - 1 of 1 Results
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer